Literature DB >> 11719914

Continuation and maintenance therapy in depression.

E S Paykel1.   

Abstract

This paper reviews longer term treatment for unipolar depression. Antidepressant continuation for prevention of early relapse has been routine for many years. Recent evidence supports a longer period of 9 months to 1 year after remission. Antidepressants are also effective in maintenance treatment for recurrent depression, and are indicated where there is clear risk of further episodes. Antidepressant withdrawal after continuation and maintenance should always be gradual, over a minimum of 3 months and longer after longer maintenance periods, to avoid withdrawal symptoms or rebound relapse. Trials of interpersonal therapy in the prevention of recurrence show some benefit, but effects are weaker than those of drug and additional benefit in combination is limited. There is better evidence for effects of cognitive therapy in preventing relapse and an emerging indication for its addition to antidepressants, particularly where residual symptoms are present.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719914     DOI: 10.1093/bmb/57.1.145

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  16 in total

Review 1.  Brief interventions for depression in primary care: a systematic review.

Authors:  Jennifer L McNaughton
Journal:  Can Fam Physician       Date:  2009-08       Impact factor: 3.275

2.  Managing Antidepressant Discontinuation: A Systematic Review.

Authors:  Emma Maund; Beth Stuart; Michael Moore; Christopher Dowrick; Adam W A Geraghty; Sarah Dawson; Tony Kendrick
Journal:  Ann Fam Med       Date:  2019-01       Impact factor: 5.166

3.  The link between depression and physical symptoms.

Authors:  Madhukar H Trivedi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

4.  Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines.

Authors:  Rachael W Taylor; Lindsey Marwood; Emanuella Oprea; Valeria DeAngel; Sarah Mather; Beatrice Valentini; Roland Zahn; Allan H Young; Anthony J Cleare
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

Review 5.  Long-term treatment of pediatric depression with psychotherapies.

Authors:  Zheya Jenny Yu; Mira Mooreville; Ronald A Weller; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

Review 6.  SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

Authors:  Gregory M Asnis; Shari R Kohn; Margaret Henderson; Nicole L Brown
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness.

Authors:  Sidney H Kennedy; Sakina J Rizvi
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

8.  Cost-effectiveness of nurse-led self-help for recurrent depression in the primary care setting: design of a pragmatic randomised controlled trial.

Authors:  Karolien E M Biesheuvel-Leliefeld; Sandra M A Kersten; Henriette E van der Horst; Anneke van Schaik; Claudi L H Bockting; Judith E Bosmans; Filip Smit; Harm W J van Marwijk
Journal:  BMC Psychiatry       Date:  2012-06-07       Impact factor: 3.630

9.  Should we treat depression with drugs or psychological interventions? A reply to Ioannidis.

Authors:  John M Davis; William J Giakas; Jie Qu; Pavan Prasad; Stefan Leucht
Journal:  Philos Ethics Humanit Med       Date:  2011-05-10       Impact factor: 2.464

10.  Stickiness of the blues: Chronicity of depression.

Authors:  G Swaminath
Journal:  Indian J Psychiatry       Date:  2009-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.